The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Flagged first, then by citations
1 of the 305 references couldn’t be matched to a known paper.
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Items 501–600 of 1,001
Xu, F., Vasilescu, D. M., Kinose, D., Tanabe, N., Ng, K. W., Coxson, H. O., Cooper, J. D., Hackett, T., Verleden, S. E., Vanaudenaerde, B. M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01411-2021 · Cited by 35
Self-citationImpaired Alveolar Re-Epithelialization in Pulmonary Emphysema
Lin, C.-R., Bahmed, K., & Kośmider, B. (2022) · Cells · doi:10.3390/cells11132055 · Cited by 39
Antioxidants and Chronic Obstructive Pulmonary Disease
Vézina, F.-A., & Cantin, A. M. (2018) · Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation · doi:10.15326/jcopdf.5.4.2018.0133 · Cited by 34
Huh, J.-Y., Hong, J., Han, D.-W., Park, Y.-J., Jung, J., & Lee, S. W. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202103-298oc · Cited by 34
Luca, S. N. D., Brassington, K., Chan, S. M. H., Dobric, A., Mou, K., Seow, H. J., & Vlahos, R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02432-y · Cited by 34
Han, H., Hu, S., & Du, J. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-03132-4 · Cited by 34
Liao, H., Pei, W., Li, H., Luo, Y., Wang, K., Li, R., Xu, L., & Chen, X. (2017) · International Journal of COPD · doi:10.2147/copd.s148422 · Cited by 34
Fibrocytes in Asthma and Chronic Obstructive Pulmonary Disease: Variations on the Same Theme
Dupin, I., Contin‐Bordes, C., & Berger, P. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0301ps · Cited by 32
The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages
Lea, S., Reynolds, S., Kaur, M., Simpson, K. D., Hall, S., Hessel, E. M., & Singh, D. (2018) · International Journal of COPD · doi:10.2147/copd.s97071 · Cited by 34
Self-citationDonner, C. F., Raskin, J. M., ZuWallack, R., Nici, L. L., Ambrosino, N., Balbi, B., Blackstock, F. C., Casaburi, R. H., Dreher, M., Effing, T., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.09.003 · Cited by 39
Longitudinal airway remodeling in active and past smokers in a lung cancer screening population
Jobst, B. J., Weinheimer, O., Buschulte, T., Trauth, M., Tremper, J., Delorme, S., Becker, N., Motsch, E., Groß, M.-L., Trotter, A., et al. (2018) · European Radiology · doi:10.1007/s00330-018-5890-4 · Cited by 34
Orme, M. W., STEINER, M. C., Morgan, M. D., Kingsnorth, A. P., Esliger, D., Singh, S., & Sherar, L. B. (2019) · International Journal of COPD · doi:10.2147/copd.s183029 · Cited by 36
Diagnosis of Chronic Obstructive Pulmonary Disease Based on Transfer Learning
Wang, Q., Wang, H., Wang, L., & Yu, F. (2020) · IEEE Access · doi:10.1109/access.2020.2979218 · Cited by 36
Liu, S., Liu, M., & Dong, L. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23410 · Cited by 34
Remote Patient Monitoring for the Detection of COPD Exacerbations
Cooper, C. B., Sirichana, W., Arnold, M. T., Neufeld, E. V., Taylor, M., Wang, X., & Dolezal, B. A. (2020) · International Journal of COPD · doi:10.2147/copd.s256907 · Cited by 34
NK Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Rao, Y., Le, Y., Xiong, J., Pei, Y., & Sun, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666045 · Cited by 34
Beghé, B., Cerri, S., Fabbri, L. M., & Marchioni, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179292 · Cited by 33
Self-citationDobric, A., Luca, S. N. D., Spencer, S. J., Bozinovski, S., Saling, M. M., McDonald, C. F., & Vlahos, R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108017 · Cited by 35
Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
Ho, T. N., Nichols, M. T., Nair, G. S., Radford, K., Kjarsgaard, M., Huang, C., Bhalla, A., LaVigne, N., Mukherjee, M., Surette, M. G., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-01929-7 · Cited by 34
Lundell, S., Toots, A., Sönnerfors, P., Halvarsson, A., & Wadell, K. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01806-9 · Cited by 34
Home based pulmonary tele-rehabilitation under telemedicine system for COPD: a cohort study
Zhang, L., Maitinuer, A., Lian, Z., Li, Y., Ding, W. Y., Wang, W., Wu, C., & Yang, X. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02077-w · Cited by 34
Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD
Smet, E. G. D., Seys, L., Verhamme, F. M., Vanaudenaerde, B. M., Brusselle, G., Bingle, C. D., & Bracke, K. R. (2017) · International Journal of COPD · doi:10.2147/copd.s144136 · Cited by 34
Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
Maddi, S., Kolsum, U., Jackson, S., Barraclough, R., Maschera, B., Simpson, K. D., Pascal, T. G., Durviaux, S. M., Hessel, E. M., & Singh, D. (2017) · International Journal of COPD · doi:10.2147/copd.s135338 · Cited by 33
Self-citationCurrow, D. C., Watts, G. J., Johnson, M. J., McDonald, C. F., Miners, J. O., Somogyi, A. A., Denehy, L., McCaffrey, N., Eckert, D. J., McCloud, P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018100 · Cited by 33
Beijers, R. J. H. C. G., Huysmans, S., van de Bool, C., Kingma, B., Verdijk, L. B., van Loon, L. J. C., Meex, S. J. R., Gosker, H. R., & Schols, A. M. W. J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.10.011 · Cited by 33
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Anzueto, A., & Miravitlles, M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.018 · Cited by 33
Self-citationGait analysis in patients with chronic obstructive pulmonary disease: a systematic review
Zago, M., Sforza, C., Bonardi, D. R., Guffanti, E. E., & Galli, M. (2018) · Gait & Posture · doi:10.1016/j.gaitpost.2018.02.007 · Cited by 37
Predictors of mortality in patients with COPD after 9 years
Prudente, R., Franco, E. A. T., Mesquita, C. B., Ferrari, R., Godoy, I., & Tanni, S. É. (2018) · International Journal of COPD · doi:10.2147/copd.s174665 · Cited by 33
The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review
Pizzini, A., Lunger, L., Sonnweber, T., Weiß, G., & Tancevski, I. (2018) · Nutrients · doi:10.3390/nu10121864 · Cited by 35
Ingadottir, A. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdottir, O. G., Ramel, A., Gislason, T., & Gunnarsdottir, I. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000349 · Cited by 33
Rehman, A. U., Hassali, M. A., Abbas, S., Ali, I. A. H., Harun, S. N., Muneswarao, J., & Hussain, R. (2019) · Journal of Public Health · doi:10.1007/s10389-019-01021-3 · Cited by 33
Cruz, T., López-Giraldo, A., Noell, G. G., Guirao, Á., Casas-Recasens, S., Garcia, T., Saco, A., Sellarés, J., Agustí, A. G. N., & Faner, R. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0351oc · Cited by 33
Self-citationEffect of periodontal therapy on COPD outcomes: a systematic review
Apessos, I., Voulgaris, A., Agrafiotis, M., Andreadis, D., & Steiropoulos, P. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01429-2 · Cited by 33
Gillenwater, L. A., Pratte, K., Hobbs, B. D., Cho, M. H., Zhuang, Y., Halper‐Stromberg, E., Cruickshank-Quinn, C. I., Reisdorph, N. A., Petrache, I., Labaki, W. W., et al. (2020) · Network and Systems Medicine · doi:10.1089/nsm.2020.0009 · Cited by 33
Leung, C., Bourbeau, J., Sin, D. D., Aaron, S. D., FitzGerald, J. M., Maltais, F., Marciniuk, D. D., O’Donnell, D. E., Hernandez, P., Chapman, K. R., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s285338 · Cited by 33
Self-citationAsthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
Jiang, L., Sun, Y., Langhammer, A., Brumpton, B. M., Chen, Y., Nilsen, T. I., Leivseth, L., Wahl, S. G. F., & Mai, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-84012-3 · Cited by 32
Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease
Waeijen-Smit, K., Houben‐Wilke, S., DiGiandomenico, A., Gehrmann, U., & Franssen, F. M. E. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02612-9 · Cited by 33
Ronish, B., Couper, D. J., Barjaktarević, I., Cooper, C. B., Kanner, R. E., Pirozzi, C. S., Kim, V., Wells, J. M., Han, M. K., Woodruff, P. G., et al. (2022) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0241 · Cited by 33
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians
Criner, G. J., Agustí, A. G. N., Borghaei, H., Friedberg, J. S., Martínez, F. J., Miyamoto, C. T., Vogelmeier, C. F., & Celli, B. R. (2022) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2022.0296 · Cited by 34
Self-citationCardiovascular predictors of mortality and exacerbations in patients with COPD
Alter, P. J., Lucke, T., Watz, H., Andreas, S., Kahnert, K., Trudzinski, F. C., Speicher, T., Söhler, S., Bals, R., Waschki, B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25938-0 · Cited by 33
Self-citationLi, X., Obeidat, M., Zhou, G., Leung, J. M., Tashkin, D. P., Wise, R. A., Connett, J. E., Joubert, P., Bossé, Y., van den Berge, M., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.020 · Cited by 33
Self-citationCOPD, airflow limitation and chronic bronchitis in farmers: a systematic review and meta-analysis
Guillien, A., Soumagne, T., Dalphin, J., & Degano, B. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2018-105310 · Cited by 33
Çolak, Y., Nordestgaard, B. G., Lange, P., Vestbo, J., & Afzal, S. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202110-2441oc · Cited by 33
Self-citationYang, T., Cai, B., Cao, B., Kang, J., Wen, F., Chen, Y., Jian, W., Shang, H., & Wang, C. (2022) · Respiratory Research · doi:10.1186/s12931-022-02021-w · Cited by 32
Insights on the mechanism of bleomycin to induce lung injury and associated in vivo models: A review
Ayilya, B. L., Balde, A., Ramya, M., Benjakul, S., Kim, S., & Nazeer, R. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110493 · Cited by 32
Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations
Su, H., Song, Y., Yang, S., Zhang, Z., Shen, Y., Yu, L., Chen, S., Gao, L., Chen, C., Hou, D., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01201 · Cited by 32
Pudi, K. K., Barnes, C. N., Moran, E. J., Haumann, B., & Kerwin, E. (2017) · Respiratory Research · doi:10.1186/s12931-017-0647-1 · Cited by 32
Mackay, A. J., Κostikas, Κ., Murray, L. T., Martínez, F. J., Miravitlles, M., Donaldson, G. C., Banerji, D. D., Patalano, F., & Wedzicha, J. A. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2482ci · Cited by 33
Self-citationViglino, D., Plazanet, A., Bailly, S., Benmerad, M., Jullian‐Desayes, I., Tamisier, R., Leroy, V., Zarski, J., Maignan, M., Joyeux‐Faure, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34988-2 · Cited by 32
Synn, A. J., Zhang, C., Washko, G. R., Estépar, R. S. J., O’Connor, G. T., Li, W., Mittleman, M. A., & Rice, M. B. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201811-795oc · Cited by 32
Wielpütz, M. O., Eichinger, M., Wege, S., Eberhardt, R., Mall, M. A., Kauczor, H., Puderbach, M., Risse, F., Heußel, C. P., & Heußel, G. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2356le · Cited by 32
Community-acquired pneumonia in chronic obstructive pulmonary disease
Cavallazzi, R., & Ramírez, J. A. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000639 · Cited by 33
Du, Y., Li, Q., Sidorenkov, G. A., Vonder, M., Cai, J., de Bock, G. H., Guan, Y., Xia, Y., Zhou, X., Zhang, D., et al. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.01.020 · Cited by 32
Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway
Zhao, K., Dong, R., Yu, Y., Tu, C., Li, Y., Cui, Y., Bao, L., & Ling, C. (2020) · Aging · doi:10.18632/aging.103180 · Cited by 32
Veith, M., Tüffers, J., Peychev, E., Klemmer, A., Kotke, V., Janciauskiene, S. M., Wilhelm, S., Bals, R., Koczulla, A. R., Vogelmeier, C. F., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s271810 · Cited by 32
Self-citationMitoquinone ameliorates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice
Yang, D., Xu, D., Wang, T., Yuan, Z., Liu, L., Shen, Y., & Wen, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107149 · Cited by 31
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
Torén, K., Schiöler, L., Lindberg, A., Andersson, A., Behndig, A., Bergström, G. M. L., Blomberg, A., Caidahl, K., Engvall, J. E., Eriksson, M. J., et al. (2020) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12684 · Cited by 32
Jang, J. G., Ahn, J. H., & Jin, H. J. (2021) · International Journal of COPD · doi:10.2147/copd.s306916 · Cited by 32
Wang, M., Lai, J., Huang, Y., Liou, J., Cheng, S.-H., Lin, C. W., Pan, H.-Y., Hsu, Y., & Tsai, C. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.05.025 · Cited by 32
Jiang, Y., Fei, J., Cao, P., Zhang, C., Tang, M., Cheng, J., Zhao, H., & Fu, L. (2021) · Environmental Toxicology · doi:10.1002/tox.23386 · Cited by 32
RetractedPavitt, M. J., Lewis, A. P., Buttery, S. C., Fernandez, B. O., Mikus-Lelinska, M., BANYA, W. A. S., Feelisch, M., Polkey, M. I., & Hopkinson, N. S. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217147 · Cited by 32
Xiao, Y., Gu, X., Niu, H., Meng, X., Zhang, L., Xu, J., Yang, L., Zhao, J., Zhang, X., Bai, C., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112877 · Cited by 32
Self-citationBlood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD)
Moon, J., Filho, F. S. L., Shahangian, K., Takiguchi, H., & Sin, D. D. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1539670 · Cited by 32
Self-citationObstructive lung diseases and risk of rheumatoid arthritis
Friedlander, H. M., Ford, J. A., Zaccardelli, A., Terrio, A. V., Cho, M. H., & Sparks, J. A. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1698293 · Cited by 34
Seeing cilia: imaging modalities for ciliary motion and clinical connections
Lever, J. E. P., Shei, R., Bermingham, B., Phillips, S. E., Turner, B., Rowe, S. M., & Solomon, G. M. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00556.2017 · Cited by 32
Bartels, W., Adamson, S., Leung, L., Sin, D. D., & van Eeden, S. F. (2018) · International Journal of COPD · doi:10.2147/copd.s163250 · Cited by 31
Self-citationLin, E., LIMPER, A. H., & Moua, T. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0673-x · Cited by 31
Chronic obstructive pulmonary disease may complicate Alzheimer’s disease: a comorbidity problem
Tondo, G., Marchi, F. D., Terazzi, E., Prandi, P., Sacchetti, M., Comi, C., & Cantello, R. M. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3470-7 · Cited by 31
Jones, R. C. M., Muyinda, H., Nyakoojo, G., Kirenga, B., Katagira, W., & Pooler, J. (2018) · International Journal of COPD · doi:10.2147/copd.s165623 · Cited by 31
Precision medicine in COPD exacerbations
Agustí, A. G. N., Faner, R., Celli, B. R., & Rodriguez‐Roisin, R. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30296-0 · Cited by 31
Self-citationCOPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study
Tsiligianni, I., Kampouraki, M., Ierodiakonou, D., Poulorinakis, I., & Papadokostakis, P. (2019) · International Journal of COPD · doi:10.2147/copd.s185362 · Cited by 31
COPD classification models and mortality prediction capacity
Arámburu, A., Aróstegui, I., Moraza, J., Barrio, I., Aburto, M., García-Loizaga, A., Uranga, A., Hernández, T. Z., Quintana, J. M., & Esteban, C. (2019) · International Journal of COPD · doi:10.2147/copd.s184695 · Cited by 31
Gawlitza, J. F., Sturm, T., Spohrer, K., Henzler, T., Akın, İ., Schönberg, S. O., Borggrefe, M. M., Haubenreisser, H., & Trinkmann, F. (2019) · Diagnostics · doi:10.3390/diagnostics9010033 · Cited by 31
Li, H., Xin, H., Yu, J., Yu, H., Zhang, J., Wang, W., & Peng, D. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00130-7 · Cited by 31
Yasuo, M., Droma, Y., Kitaguchi, Y., Ito, M., Imamura, H., Kawakubo, M., & Hanaoka, M. (2019) · International Journal of COPD · doi:10.2147/copd.s208633 · Cited by 31
Tanno, A., Fujino, N., Yamada, M., Sugiura, H., Hirano, T., Tanaka, R., Sano, H., Suzuki, S. O., Okada, Y., & Ichinose, M. (2020) · Respiratory Research · doi:10.1186/s12931-020-1297-2 · Cited by 36
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
Zhang, W. Z., Oromendia, C., Kikkers, S. A., Butler, J. J., O’Beirne, S. L., Kim, K., O’Neal, W. K., Freeman, C. M., Christenson, S. A., Peters, S. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67047-w · Cited by 31
Self-citationCasas-Recasens, S., Noell, G. G., Mendoza, N., López-Giraldo, A., Garcia, T., Guirao, Á., Agustí, A. G. N., & Faner, R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2420le · Cited by 29
Self-citationCumulative Occupational Exposures and Lung-Function Decline in Two Large General-Population Cohorts
Lytras, T., Beckmeyer-Borowko, A., Kogevinas, M., Kromhout, H., Carsin, A., Antó, J. M., Bentouhami, H., Weyler, J., Heinrich, J., Nowak, D., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202002-113oc · Cited by 32
Li, L., Zhong, X., Zheng, A., JianKun, C., Budukadeer, A. A., Aini, P., Tuerxun, M., Yasen, M., Ma, T., Ren, J., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s289620 · Cited by 31
Mummy, D. G., Coleman, E. M., Wang, Z., Bier, E. A., Lu, J., Driehuys, B., & Huang, Y.-C. T. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27662 · Cited by 31
Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa
Mahomed, T. G., Peters, R. P. H., Allam, M., Ismail, A., Mtshali, S., Mahomed, A. G., Ueckermann, V., Kock, M. M., & Ehlers, M. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99127-w · Cited by 30
Cellular senescence—an aging hallmark in chronic obstructive pulmonary disease pathogenesis
Araya, J., & Kuwano, K. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.09.003 · Cited by 32
Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity
Baugh, A. D., Buhr, R. G., Quibrera, P. M., Barjaktarević, I., Barr, R. G., Bowler, R. P., Han, M. K., Kaufman, J. D., Koch, A. L., Krishnan, J. A., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac107 · Cited by 37
Zhou, L., Yang, H., Zhang, Y., Li, H., Zhang, S., Li, D., Ma, Y., Hou, Y., Lu, W., & Wang, Y. (2022) · Age and Ageing · doi:10.1093/ageing/afac269 · Cited by 30
Cook, S., Hirschtick, J. L., Fleischer, N. L., Arenberg, D. A., Barnes, G. D., Levy, D. T., Sánchez‐Romero, L. M., Jeon, J., & Meza, R. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.038 · Cited by 35
Jobst, B. J., Weinheimer, O., Trauth, M., Becker, N., Motsch, E., Groß, M.-L., Tremper, J., Delorme, S., Eigentopf, A., Eichinger, M., et al. (2017) · European Radiology · doi:10.1007/s00330-017-5030-6 · Cited by 31
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
Labaki, W. W., Gu, T., Murray, S., Curtis, J. L., Yeomans, L., Bowler, R. P., Barr, R. G., Comellas, A. P., Hansel, N. N., Cooper, C. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47761-w · Cited by 33
Respiratory Symptoms and Lung Function among Ethiopian Women in Relation to Household Fuel Use
Tamire, M., Addissie, A., Kumie, A., Husmark, E., Skovbjerg, S., Andersson, R., & Lärstad, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010041 · Cited by 31
Mental health and sleep quality among patients with asthma and COPD
Aldabayan, Y. S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1181742 · Cited by 31
Does Rheumatoid Arthritis Increase the Risk of COPD?
Chung, C., Kim, H., Han, K., Jung, J., Eun, Y., Lee, H., Park, J., Shin, D. W., & Lee, S. W. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.02.014 · Cited by 30
Cho, Y. H., Lee, S. M., Seo, J. B., Kim, N., Bae, J.-P., Lee, J. S., Oh, Y., & Do-Lee, S. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.09.013 · Cited by 28
Aksu, U., Gülcü, O., Aksakal, E., Kalkan, K., Öztürk, M., Korkmaz, A. F., Uslu, A., & Demirelli, S. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22848 · Cited by 30
Zayed, Y., Barbarawi, M., Kheiri, B., Haykal, T., Chahine, A., Rashdan, L., Hamid, K. A., Sundus, S., Banifadel, M., Aburahma, A., et al. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13026 · Cited by 30
Ferguson, G. T., Feldman, G., Pudi, K. K., Barnes, C. N., Moran, E. J., Haumann, B., Pendyala, S., & Crater, G. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.2.2018.0152 · Cited by 30
Saferali, A., Yun, J. H., Parker, M. M., Sakornsakolpat, P., Chase, R., Lamb, A. E., Hobbs, B. D., Boezen, M., Dai, X., de Jong, K., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008229 · Cited by 30
Chronic Obstructive Pulmonary Disease and Heart Failure
Pellicori, P., Cleland, J. G. F., & Clark, A. L. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.08.003 · Cited by 30
Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease
Diao, W., Labaki, W. W., Han, M. K., Yeomans, L., Sun, Y., Smiley, Z., Kim, J. H., McHugh, C. E., Xiang, P., Shen, N., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s210598 · Cited by 29
Zhao, Z., Chang, M.-Y., Frerichs, I., Zhang, J., Chang, H., Gow, C., & Möller, K. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.19.13732-7 · Cited by 30
Maynard-Paquette, A.-C., Poirier, C., Chartrand‐Lefebvre, C., & Dubé, B. (2020) · International Journal of COPD · doi:10.2147/copd.s222945 · Cited by 30
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
